cormorant Lp Biography and Net Worth



cormorant Lp is the Insider of Aerovate Therapeutics.

How do I contact cormorant Management Lp?

The corporate mailing address for Lp and other Aerovate Therapeutics executives is , , . Aerovate Therapeutics can also be reached via phone at 617-443-2400 and via email at [email protected]. Learn More on cormorant Management Lp's contact information.

Has cormorant Management Lp been buying or selling shares of Aerovate Therapeutics?

cormorant Management Lp has not been actively trading shares of Aerovate Therapeutics during the last quarter. Learn More on cormorant Management Lp's trading history.

Who are Aerovate Therapeutics' active insiders?

Aerovate Therapeutics' insider roster includes Benjamin Dake (Insider), cormorant Lp (Insider), and Timothy Noyes (CEO). Learn More on Aerovate Therapeutics' active insiders.

cormorant Management Lp Insider Trading History at Aerovate Therapeutics

See Full Table

cormorant Management Lp Buying and Selling Activity at Aerovate Therapeutics

This chart shows Cormorant Asset Management, Lp's buying and selling at Aerovate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aerovate Therapeutics Company Overview

Aerovate Therapeutics logo
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $12.00
Low: $11.32
High: $12.40

50 Day Range

MA: $10.13
Low: $8.06
High: $12.82

2 Week Range

Now: $12.00
Low: $56.35
High: $105.00

Volume

246,525 shs

Average Volume

12,438 shs

Market Capitalization

$347.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95